+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Liver Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 143 Pages
  • March 2022
  • Region: Global
  • IMARC Group
  • ID: 5562509
UP TO OFF until Dec 31st 2022
The global liver disease treatment market reached a value of US$ 20.83 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 30.91 Billion by 2027 exhibiting a CAGR of 6.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.



The liver is a vital organ of the human body that performs significant functions, such as storing vitamins and nutrients, removing harmful substances from the blood, and maintaining an adequate balance of chemicals in the body. Cancer, hepatitis, autoimmune diseases, and genetic disorders are some common liver diseases. These diseases are commonly caused by infections, genetics, obesity, diabetes, and immune system abnormalities. Some of the widely used therapeutic techniques for liver diseases include vaccines, chemotherapy, antiviral drugs, immunoglobulins, corticosteroids, and immunosuppressants. Liver disease treatment aids in the excretion of cholesterol and hormones, increases bile production and enzyme activation.

Liver Disease Treatment Market Trends:


The rising geriatric population, which is suspetible to various chronic ailments, including liver disease, across the globe is one of the prime factors driving the growth of the market. The changing dietary patterns and sedentary lifestyles are boosting the market growth. Additionally, the increasing prevalence of fatty liver disease due to high cholesterol, obesity, hypertension (high blood pressure), and diabetes is favoring the market growth. Moreover, various technological advancements, such as the development of the bioartificial liver, are providing an impetus to the market growth. It utilizes regenerated liver cells to replace liver functions and is widely used for acute liver failure patients. In line with this, the rapid adoption of antiviral drugs as they are safe and effective, assist in suppressing the hepatitis B virus, and help in reducing the risk of developing cirrhosis and hepatocellular carcinoma, is positively impacting the market growth. Apart from this, increasing research and development (R&D) activities, significant growth in the healthcare industry, and the implementation of various government initiatives to promote public health are creating a positive outlook for the market.

Key Market Segmentation:


The publisher provides an analysis of the key trends in each sub-segment of the global liver disease treatment market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on treatment type, disease type and end user.

Breakup by Treatment Type:

  • Antiviral Drugs
  • Immunosuppressants
  • Vaccines
  • Immunoglobulins
  • Corticosteroids
  • Targeted Therapy
  • Chemotherapy

Breakup by Disease Type:

  • Hepatitis
  • Autoimmune Diseases
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Cancer
  • Genetic Disorders
  • Others

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:


The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.

Key Questions Answered in This Report:


  • How has the global liver disease treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global liver disease treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the disease type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global liver disease treatment market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Liver Disease Treatment Market

What is the estimated value of the Global Liver Disease Treatment Market?

The Global Liver Disease Treatment Market was estimated to be valued at $20.83 Billion in 2021.

What is the growth rate of the Global Liver Disease Treatment Market?

The growth rate of the Global Liver Disease Treatment Market is 6.8%, with an estimated value of $30.91 Billion by 2027.

What is the forecasted size of the Global Liver Disease Treatment Market?

The Global Liver Disease Treatment Market is estimated to be worth $30.91 Billion by 2027.

Who are the key companies in the Global Liver Disease Treatment Market?

Key companies in the Global Liver Disease Treatment Market include Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol, Myers Squibb Company, Eli Lilly, Company, Emergent BioSolutions Inc. and La Roche AG.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Liver Disease Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Treatment Type
6.1 Antiviral Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Immunosuppressants
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Vaccines
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Immunoglobulins
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Corticosteroids
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Targeted Therapy
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Chemotherapy
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Disease Type
7.1 Hepatitis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Autoimmune Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Non-alcoholic Fatty Liver Disease (NAFLD)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cancer
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Genetic Disorders
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AbbVie Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Astellas Pharma Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Eli Lilly and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Emergent BioSolutions Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 F. Hoffmann-La Roche AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Gilead Sciences Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 GlaxoSmithKline plc
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Merck & Co. Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Novartis AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Pfizer Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Sanofi S.A.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
14.3.14 Takeda Pharmaceutical Company Limited
14.3.14.1 Company Overview
14.3.14.2 Product Portfolio
14.3.14.3 Financials
14.3.14.4 SWOT Analysis
14.3.15 Viatris Inc.
14.3.15.1 Company Overview
14.3.15.2 Product Portfolio
14.3.15.3 Financials
List of Figures
Figure 1: Global: Liver Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Liver Disease Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Liver Disease Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Liver Disease Treatment Market: Breakup by Treatment Type (in %), 2021
Figure 5: Global: Liver Disease Treatment Market: Breakup by Disease Type (in %), 2021
Figure 6: Global: Liver Disease Treatment Market: Breakup by End User (in %), 2021
Figure 7: Global: Liver Disease Treatment Market: Breakup by Region (in %), 2021
Figure 8: Global: Liver Disease Treatment (Antiviral Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Liver Disease Treatment (Antiviral Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Liver Disease Treatment (Immunosuppressants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Liver Disease Treatment (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Liver Disease Treatment (Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Liver Disease Treatment (Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Liver Disease Treatment (Immunoglobulins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Liver Disease Treatment (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Liver Disease Treatment (Corticosteroids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Liver Disease Treatment (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Liver Disease Treatment (Targeted Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Liver Disease Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Liver Disease Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Liver Disease Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Liver Disease Treatment (Hepatitis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Liver Disease Treatment (Hepatitis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Liver Disease Treatment (Autoimmune Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Liver Disease Treatment (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Liver Disease Treatment (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Liver Disease Treatment (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Liver Disease Treatment (Genetic Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Liver Disease Treatment (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Liver Disease Treatment (Other Disease Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Liver Disease Treatment (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Liver Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Liver Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Liver Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Liver Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: North America: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: North America: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: United States: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: United States: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Canada: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Canada: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Asia-Pacific: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Asia-Pacific: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: China: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: China: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Japan: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Japan: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: India: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: India: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: South Korea: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: South Korea: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Australia: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Australia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Indonesia: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Indonesia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Europe: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Europe: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Germany: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Germany: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: France: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: France: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: United Kingdom: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: United Kingdom: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Italy: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Italy: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Spain: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Spain: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Russia: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Russia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Latin America: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Latin America: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Brazil: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Brazil: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Mexico: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Mexico: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Middle East and Africa: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Middle East and Africa: Liver Disease Treatment Market: Breakup by Country (in %), 2021
Figure 88: Middle East and Africa: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Liver Disease Treatment Industry: SWOT Analysis
Figure 90: Global: Liver Disease Treatment Industry: Value Chain Analysis
Figure 91: Global: Liver Disease Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Liver Disease Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Liver Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
Table 3: Global: Liver Disease Treatment Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 4: Global: Liver Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Liver Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Liver Disease Treatment Market: Competitive Structure
Table 7: Global: Liver Disease Treatment Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly
  • Company
  • Emergent BioSolutions Inc.
  • F. Hoffmann-La Roche AG
  • Gilead Sciences Inc.
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc.

Methodology

Loading
LOADING...